![Hong Sheng Xu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hong Sheng Xu
Algemeen Directeur bij Shapuaisi Qiangshen Pharma Co., Ltd.
Actieve functies van Hong Sheng Xu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Shapuaisi Qiangshen Pharma Co., Ltd.
![]() Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - |
Loopbaan van Hong Sheng Xu
Eerdere bekende functies van Hong Sheng Xu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Directeur/Bestuurslid | 25-09-2018 | - |
Voorzitter | 25-09-2018 | - |
Statistieken
Internationaal
China | 3 |
Operationeel
Director/Board Member | 2 |
Chairman | 1 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Shapuaisi Qiangshen Pharma Co., Ltd.
![]() Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million. | Health Technology |
- Beurs
- Insiders
- Hong Sheng Xu
- Ervaring